3-oxo-N-phenylundecanamide
ID: ALA4474499
PubChem CID: 155537047
Max Phase: Preclinical
Molecular Formula: C17H25NO2
Molecular Weight: 275.39
Molecule Type: Unknown
Associated Items:
This compound is not in our inventory system
ID: ALA4474499
PubChem CID: 155537047
Max Phase: Preclinical
Molecular Formula: C17H25NO2
Molecular Weight: 275.39
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCCCCC(=O)CC(=O)Nc1ccccc1
Standard InChI: InChI=1S/C17H25NO2/c1-2-3-4-5-6-10-13-16(19)14-17(20)18-15-11-8-7-9-12-15/h7-9,11-12H,2-6,10,13-14H2,1H3,(H,18,20)
Standard InChI Key: OGPXIHNIKGFTIV-UHFFFAOYSA-N
Molfile:
RDKit 2D 20 20 0 0 0 0 0 0 0 0999 V2000 17.7848 -10.4660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.4980 -10.8806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 19.2113 -10.4660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 19.9244 -10.8806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 20.6376 -10.4660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 21.3509 -10.8806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 22.0600 -10.4660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 22.7731 -10.8806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 23.4863 -10.4660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 24.1996 -10.8806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 24.9128 -10.4660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 23.4863 -9.6408 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 24.9128 -9.6408 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 25.6283 -10.8802 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 26.3432 -10.4652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 27.0554 -10.8805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 27.7656 -10.4661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 27.7656 -9.6400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 27.0494 -9.2301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 26.3379 -9.6428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 1 0 4 5 1 0 5 6 1 0 6 7 1 0 7 8 1 0 8 9 1 0 9 10 1 0 10 11 1 0 9 12 2 0 11 13 2 0 11 14 1 0 14 15 1 0 15 16 2 0 16 17 1 0 17 18 2 0 18 19 1 0 19 20 2 0 20 15 1 0 M END
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 275.39 | Molecular Weight (Monoisotopic): 275.1885 | AlogP: 4.33 | #Rotatable Bonds: 10 |
Polar Surface Area: 46.17 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.53 | CX Basic pKa: ┄ | CX LogP: 4.80 | CX LogD: 4.80 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.51 | Np Likeness Score: -0.24 |
1. Chbib C.. (2020) Impact of the structure-activity relationship of AHL analogues on quorum sensing in Gram-negative bacteria., 28 (3): [PMID:31918952] [10.1016/j.bmc.2019.115282] |
Source(1):